A TRPV1 antagonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

AMG 517

Item No. 26191

Technical Information
Formal Name
N-[4-[[6-[4-(trifluoromethyl)phenyl]-4-pyrimidinyl]oxy]-2-benzothiazolyl]-acetamide
CAS Number
659730-32-2
Molecular Formula
C20H13F3N4O2S
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 112.5 mg/mlDMSO: 14.3 mg/mlEthanol: 3.3 mg/ml
λmax
247, 272 nm
SMILES
O=C(C)NC1=NC2=C(S1)C=CC=C2OC3=NC=NC(C4=CC=C(C(F)(F)F)C=C4)=C3
InChi Code
InChI=1S/C20H13F3N4O2S/c1-11(28)26-19-27-18-15(3-2-4-16(18)30-19)29-17-9-14(24-10-25-17)12-5-7-13(8-6-12)20(21,22)23/h2-10H,1H3,(H,26,27,28)
InChi Key
YUTIXVXZQIQWGY-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    AMG 517 is an antagonist of transient receptor potential vanilloid 1 (TRPV1; IC50 = 0.9 nM).1 It inhibits mechanical and thermal allodynia in a rat model of burn injury when administered intrathecally at a dose of 165 µg.2 AMG 517 (150 and 300 µg/kg) also reverses increases in the level of calcitonin gene-related peptide (CGRP) and increases expression of GFAP and GAP-43 in the dorsal horn of the spinal cord, as well as enhances axonal regeneration in a rat model of sciatic nerve transection injury.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Blum, C.A., Caldwell, T., Zheng, X., et alDiscovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonists. J. Med. Chem. 53(8), 3330-3348 (2010).

    2. Green, D.P., Ruparel, S., Gao, X., et alCentral activation of TRPV1 and TRPA1 by novel endogenous agonists contributes to mechanical allodynia and thermal hyperalgesia after burn injury. Mol. Pain 12, (2016).

    3. Bai, J., Liu, F., Wu, L.-F., et alAttenuation of TRPV1 by AMG-517 after nerve injury promotes peripheral axonal regeneration in rats. Mol. Pain 14, 1-10 (2018).